임신 중 dipropylene glycol salicylate을 피해야 할까요? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

dipropylene glycol salicylate은 임신 중 안전한가요?

No evidence of a harmonised CLP H360 or an EU Annex II/III restriction for dipropylene glycol salicylate was found (no EU ban/restriction). Several safety sources treat it as an ester of salicylic acid; the CIR assessment of salicylic acid/salicylates and government reviews report reproductive/developmental effects only at relatively high systemic doses in animals, not from topical cosmetic use. Some SDSs list H361 but these appear to be company self-classifications rather than a harmonised ECHA classification. Given the structural link to salicylic acid (structural/class-based concern) but absence of harmonised classification or robust reproductive studies on this exact compound, I assign a conservative h=1 (structural/class concern), m=1 (theoretical/mechanistic plausibility via ester → salicylate), e=1 (low but measurable dermal exposure for typical cosmetic use). Sources: PubChem, CIR salicylates review, Canada draft screening (salicylates), EWG, manufacturer/SDS notes.

dipropylene glycol salicylate은 모유 수유 중 안전한가요?

Same rationale as pregnancy: no direct harmonised reproductive classification or authoritative restriction for this specific ester, but it is an ester of salicylic acid which can be systemically active after absorption/hydrolysis. Dermal cosmetic use is expected to give low but measurable maternal systemic exposure in normal use; transfer into breastmilk would be contingent on maternal systemic levels. Conservative approach: same scores as pregnancy.

dipropylene glycol salicylate은 아기 피부에 안전한가요?

Hazard (h) and mechanism (m) unchanged — no infant-specific reproductive/developmental data; however exposure (e) increased by +1 because infant skin (0–3 y) has higher surface-area-to-body-weight and an immature barrier, so measured dermal absorption for the parent compound would translate to higher internal exposure in infants. There is no evidence that infant topical use has produced harm for this specific ingredient, but prudence supports increased exposure score for baby skin.

VeriMom은 dipropylene glycol salicylate을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 dipropylene glycol salicylate을 27/100 (높은 위험)로 평가합니다.

임신 중 dipropylene glycol salicylate 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.